JP Morgan Chase
SLRN

JP Morgan Chase’s ACELYRIN SLRN Stock Holding History

JP Morgan Chase’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-590,846
Closed -$1.46M – 7591
2025
Q1 		$1.46M Sell
590,846
-27,281
-4% -$64.9K ﹤0.01% 4086
2024
Q4 		$1.94M Sell
618,127
-232,534
-27% -$1.13M ﹤0.01% 4180
2024
Q3 		$4.19M Sell
850,661
-1,747,642
-67% -$9.02M ﹤0.01% 3340
2024
Q2 		$11.5M Buy
2,598,303
+6,499
+0.3% +$30.5K ﹤0.01% 2338
2024
Q1 		$17.5M Sell
2,591,804
-596,673
-19% -$4.53M ﹤0.01% 2000
2023
Q4 		$23.8M Buy
3,188,477
+24,386
+0.8% +$208K ﹤0.01% 1703
2023
Q3 		$32.2M Sell
3,164,091
-539,247
-15% -$11.5M ﹤0.01% 1344
2023
Q2 		$77.4M Buy
+3,703,338
New +$75.7M 0.01% 940

Other funds holding SLRN

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's SLRN Position: Q2 2025 in Review

JP Morgan Chase sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 590,846 shares — an estimated $1.46M sold.

JP Morgan Chase first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $77.4M in Q2 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • JP Morgan Chase reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 590,846 ACELYRIN shares in Q2 2025, an estimated $1.46M.
  • JP Morgan Chase first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
  • JP Morgan Chase's ACELYRIN position peaked at $77.4M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.